Humacyte, Inc. (HUMA) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
Humacyte, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Humacyte, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($166.7M and $166.4M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against 149.8%. Tonix Pharmaceuticals Holding Corp. has the higher net margin (−548.6% vs −4,448.9%) and the higher return on invested capital (−224.5% vs −433.7%). Across the 17 metrics below, Tonix Pharmaceuticals Holding Corp. leads on 13 and Humacyte, Inc. on 4.
Valuation
Profitability
| Metric | HUMA | TNXP | Biotechnology median |
|---|---|---|---|
| Gross margin | (494.58%) | 83.83% | 65.16% |
| Operating margin | (5,240.78%) | (568.43%) | 0.00% |
| Net margin | (4,448.89%) | (548.64%) | 0.00% |
| Free cash flow margin | (4,599.72%) | (543.29%) | 0.00% |
| Return on equity | (534.42%) | (81.82%) | (57.72%) |
| Return on assets | (68.16%) | (72.34%) | (49.22%) |
| Return on invested capital | (433.66%) | (224.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack